Advance in the study of inhibin, activin and follistatin production in pregnant women.
This review summarizes the new information on the studies of inhibin, activin, and follistatin production in the placenta during human pregnancy. Inhibin and activin exert suppressive and stimulatory effects, respectively, on the release of FSH in the pituitary. Follistatin is bound to inhibin and activin and indirectly modulates the FSH release. The placenta produces these three proteins. The serum levels of inhibin, activin, and follistatin are elevated in pregnant women and decrease after delivery. The trophoblast cells from term placenta secrete inhibin and activin in the primary cultures. The production and mRNA expression of inhibin and activin are regulated by several stimulatory and suppressive hormones and growth factors in placental tissues. cAMP, Ca2+, and protein kinase-C may be involved in intracellular signal transduction in trophoblasts. Activin receptors are present on placental cells. Follistatin inhibits the binding of activin to ActRII receptor. Abnormal levels of inhibin and activin in maternal serum are observed in problem pregnancies and gestational diseases. Inhibin, activin, and follistatin may play roles in the regulation of reproductive endocrinology in pregnant women and the embryo/fetal development.
Qu
J
J
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Louvain, Brussels, Belgium.
Thomas
K
K
D029404:Activin Receptors; D028341:Activins; D005260:Female; D038681:Follistatin; D006023:Glycoproteins / Q000096:biosynthesis*; D006801:Humans; D007265:Inhibins / Q000096:biosynthesis*; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy / Q000378:metabolism*; D017978:Receptors, Growth Factor / Q000032:analysis; D018000:Receptors, Peptide / Q000032:analysis